IWP-4 (CAS: 686772-17-8)
|
SKU-Pack Size | Availability | Size | Price | |
EBC51122-1ML | In Stock | 1mL(10mM in DMSO) | €245.70 | |
EBC51122-1MG | In Stock | 1mg | €76.70 | |
EBC51122-5MG | In Stock | 5mg | €180.70 | |
EBC51122-10MG | In Stock | 10mg | €258.70 | |
EBC51122-25MG | In Stock | 25mg | €518.70 |
Please Select The Country You Are In To Find Your Local Distributor. |
Cambiotech | Phone£º+44 (0) 188 448801 | |
Lanwades Business Park, | E-mail£ºinfo@cambiotech.com | |
Ireland | Kobenhavn K, Ireland | Web£ºwww.cambiotech.com |
Product Information | |||||||||||||||||||||
Synonym(s) | Inhibitor of Wnt Production-4, IWP 4, IWP4 | ||||||||||||||||||||
Chemical Name | N-(6-Methyl-2-benzothiazolyl)-2-[[3,4,6,7-tetrahydro-3-(2-methoxyphenyl)-4- oxothieno[3,2-d]pyrimidin-2-yl]thio]acetamide | ||||||||||||||||||||
Application | IWP-4 is a Wnt pathway inhibitor | ||||||||||||||||||||
CAS Number | 686772-17-8 | ||||||||||||||||||||
Purity | ¡Ý98.0% | ||||||||||||||||||||
Molecular Weight | 496.62 | ||||||||||||||||||||
Molecular Formula | C₂₃H₂₀N₄O₃S₃ | ||||||||||||||||||||
SMILES | O=C(NC1=NC2=CC=C(C)C=C2S1)CSC3=NC(CCS4)=C4C(N3C5=CC=CC=C5OC)=O | ||||||||||||||||||||
Target & IC50 | Wnt: IC50 = 25 nM | ||||||||||||||||||||
Solubility | DMSO: 2 mg/ml | ||||||||||||||||||||
Preparing Stock Solutions |
|
||||||||||||||||||||
Shipping | Gel Pack | ||||||||||||||||||||
Storage | Store at -20¡ãC | ||||||||||||||||||||
Research Use | For Research Use Only. Not Intended for Diagnostic Or Therapeutic Use. |
Product Description | |
IWP-4 is a potent inhibitor of Wnt production that blocks Wnt pathway activity in vitro (IC₅₀ = 25 nM). IWP-4 inactivates Porcupine (porcn), a membrane-bound O-acyltransferase responsible for palmitoylating Wnt proteins, which is essential for their signaling ability and secretion. At 5 μM, IWP-4 has been shown to block Wnt-dependent phosphorylation of the low-density lipoprotein receptor-related protein 6 receptor and the scaffold protein Dishevelled, preventing the accumulation of β-catenin. IWP-4 has been used to induce cardiomyocyte differentiation from human pluripotent stem cells. |
Specific Protocols | |